Answer
Liver enzyme monitoring should be considered during the first 6–12 months of acarbose treatment because fulminant hepatitis has been reported and acarbose may contribute to liver injury, although the mechanism is unknown.
Sources for this answer
- Acarbose 100 mg TabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked